Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-122
Closed -$2K 527
2020
Q2
$2K Buy
+122
New +$851 ﹤0.01% 463
2019
Q4
Sell
-16,035
Closed -$368K 497
2019
Q3
$368K Buy
16,035
+1,544
+11% +$35.4K 0.24% 319
2019
Q2
$372K Buy
14,491
+5,227
+56% +$163K 0.3% 5
2019
Q1
$335K Buy
9,264
+418
+5% +$14.3K 0.29% 105
2018
Q4
$255K Buy
+8,846
New +$381K 0.18% 153
2018
Q3
Sell
-2,825
Closed -$184K 488
2018
Q2
$184K Sell
2,825
-587
-17% -$36.8K 0.31% 19
2018
Q1
$188K Buy
3,412
+3,388
+14,117% +$201K 0.24% 146
2017
Q4
$2K Buy
+24
New +$1.42K ﹤0.01% 463

Other funds holding OVV

Cerebellum's OVV Position: Q3 2020 in Review

Cerebellum sold out of Ovintiv (OVV) in Q3 2020, closing a stake of 122 shares — an estimated $2K sold.

Cerebellum first reported a position in OVV in Q4 2017 and held it in 8 quarters. The position peaked at $372K in Q2 2019. 253 funds tracked by Wall St. Rank hold OVV as of Q3 2020.

  • Cerebellum reported no remaining Ovintiv position as of Q3 2020 after selling out during the quarter.
  • Cerebellum sold 122 Ovintiv shares in Q3 2020, an estimated $2K.
  • Cerebellum first reported a position in Ovintiv in Q4 2017 and held it in 8 quarters.
  • Cerebellum's Ovintiv position peaked at $372K in Q2 2019.
  • 253 funds tracked by Wall St. Rank held Ovintiv as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.